Financial Daily from THE HINDU group of publications
Thursday, Jan 30, 2003
Financial Daily from THE HINDU group of publications Thursday, Jan 30, 2003 |
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Corporate - Financial Performance Zydus Cadila net rises 18 pc in Q3 Our Bureau
MUMBAI, Jan. 29 ZYDUS Cadila has recorded a 18 per cent rise in net profit at Rs 17.29 crore in the third quarter ended December 31, 2002 as against Rs 14.70 crore in the corresponding period last year. According to the company, the increased sales of the products, Amlodac and Falcigo contributed to the growth in sales. Penegra, the sildenafil citrate product has a market share of 25 per cent and is the leader in the segment, the company claims. Net sales were up at Rs 166.63 crore (Rs 151.84 crore). Other income has dropped to Rs 29.67 lakh (Rs 43.40 lakh). Total expenditure has risen to Rs 140.35 crore (Rs 128.27 crore). Depreciation was at Rs 6.51 crore (Rs 5.25 crore). Provision for tax has increased to Rs 7.85 crore (Rs 2.17 crore).
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|